首页> 外国专利> IMIDAZOYLALKYL SUBSTITUTED WITH A FIVE, SIX OR SEVEN MEMBERED HETEROCYCLIC RING CONTAINING ONE NITROGEN ATOM

IMIDAZOYLALKYL SUBSTITUTED WITH A FIVE, SIX OR SEVEN MEMBERED HETEROCYCLIC RING CONTAINING ONE NITROGEN ATOM

机译:含五个氮原子的五个,六个或七个花环的咪唑基烷基取代基

摘要

Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a Compound of Formula (I). Further disclosed is a method of treating allergy (for example asthma), inflammation, hypotension, raised intraocular pressure (such as glaucoma) i.e., a method of lowering intraocular pressure, sleeping disorders, states of hyper and hypo motility and acidic secretion of the gastrointestinal tract, hypo and hyperactivity of the central nervous system (for example, agitation and depression) and other CNS disorders (such as Alzheimer's, Schizophrenia, obesity and migraine) comprising administering an effective amount of a compound of Formula (I) to a patient in need of such treatment. Also disclosed are methods for treatment of upper airway allergic responses comprising administering a compound, or salt or solvate thereof, of Formula (I) in combination or admixture with a histamine H1 receptor antagonist.
机译:公开了式(I)的化合物或其药学上可接受的盐或溶剂化物。还公开了包含药学上可接受的载体和有效量的式(I)化合物的药物组合物。进一步公开了一种治疗变态反应(例如哮喘),炎症,低血压,眼内压升高(例如青光眼)的方法,即降低眼内压,睡眠障碍,运动过度和运动不足状态以及胃肠道酸性分泌的方法。中枢神经系统(例如躁动和抑郁)和其他中枢神经系统疾病(例如阿尔茨海默氏症,精神分裂症,肥胖症和偏头痛)的道,功能减退和活动亢进,包括向患者服用有效量的式(I)化合物需要这种治疗。还公开了用于治疗上呼吸道过敏反应的方法,其包括与组胺H1受体拮抗剂组合或混合施用式(I)的化合物或其盐或溶剂化物。

著录项

  • 公开/公告号IL135727D0

    专利类型

  • 公开/公告日2001-05-20

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号IL19980135727

  • 发明设计人

    申请日1998-11-05

  • 分类号7C07DA;

  • 国家 IL

  • 入库时间 2022-08-22 01:24:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号